Laccourreye, O, Mirghani, H, Guiquerro, S, Quer, M, Giraud, P. Perception of survival/laryngeal preservation trade-off in advanced T-stage laryngeal cancer. European Annals of Otorhinolaryngology-Head and Neck Diseases. 2023; 140(2)DOI:10.1016/j.anorl.2022.12.008. PMID:36642664. IF:1.900(Q2/3D).

Sanmarti, R, Corominas, H. Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review. Journal of Clinical Medicine. 2023; 12(5)DOI:10.3390/jcm12051734. PMID:36902522. IF:3.000(Q1/2D).

Subiela J.D., Rodríguez Faba Ó., Aumatell J., Gonzalez-Padilla D.A., Rosales Bordes A., Huguet J., Krajewski W., Algaba F., López Curtis D., Brasero Burgos J., Sánchez González Á., Jiménez Cidre M.Á., Burgos Revilla F.J., Breda A., Palou J.. Long-term Recurrence and Progression Patterns in a Contemporary Series of Patients with Carcinoma In Situ of the Bladder With or Without Associated Ta/T1 Disease Treated with Bacillus Calmette-Guérin: Implications for Risk-adapted Follow-up. European Urology Focus. 2023; 9(2)DOI:10.1016/j.euf.2022.09.007. PMID:36163105. IF:4.900(Q1/2D).

Bermudez-Tamayo, C, Hernandez, MN, Alguacil, J, Cantarero, D, Portino, MC, Casino, G, Calvente, MG, Hernan, M, Garcia, LP, Cantero, MTR, Segura, A, Amez, JG, Juarez, L, Miranda, JJ, March, JC, Marcos-Marcos, J, Mar, J, Peiro, R, Alvarez-Dardet, C. GACETA SANITARIA in 2022. Maximum historical impact factor and suitability for continuous publication. Gaceta Sanitaria. 2023; 37DOI:10.1016/j.gaceta.2023.102295. PMID:36871443. IF:1.500(Q3/7D).